The first Swiss project on the legal sale of cannabis in pharmacies will start on September 15 in canton Basel City. Hemp users over 18 can now register to take part, with the number of participants limited to 370.
This content was published on
1 minute
Keystone-SDA/ts/ug
Español
es
Test: Venta de cannabis en farmacias suizas a precios de mercado negro
Six cannabinoid products – four types of cannabis flowers and two types of hashish – will be sold in nine pharmacies selected by the authorities, cantonal health minister Lukas Engelberger said on Thursday.
The prices charged by the pharmacies will be around those charged on the black market for products with a THC content. A gram will therefore cost CHF8-CHF12 ($8.40-$12.60).
The Federal Office of Public Health approved the pilot in April. It will be part of a project by the University of Basel, its psychiatric clinics and the cantonal health department.
It is intended to help evaluate the effects of new regulations on the recreational use of cannabis and ultimately combat black market distribution.
Legal ban
Several other local authorities, including Zurich, Geneva and Bern, have also applied to roll out similar trials. The Swiss parliament laid the legal basis for such small-scale initiatives in September 2020.
The health office estimates there are 220,000 regular consumers of cannabis in Switzerland despite a legal ban. The use of cannabis is only allowed for medical reasons.
In 2008 almost two-thirds of Swiss voters rejected an initiative to decriminalise cannabis consumption; it was the second national vote on the issue in a decade.
More
More
Swiss cannabis market – a delicate balancing act
This content was published on
Producing and selling hemp inflorescences with low THC content has been legal in Switzerland since 2017. But the market hasn’t been a gold mine.
Swiss study: Arabica cultivation areas could be halved by 2050
This content was published on
Around the world, the areas most suitable for growing the bean could even shrink by 60% if greenhouse gas emissions remain high.
This content was published on
The UN Human Rights Council approved the launch of this mechanism in Geneva on Friday, to be followed by an International Commission of Inquiry.
More than 100 wolves shot in Switzerland last year
This content was published on
Swiss hunters legally killed 101 wolves between February 1, 2024, and the end of January 2025. A further six died in accidents or from natural causes.
Swiss health office turns to Bluesky against backdrop of US censorship
This content was published on
The Swiss Federal Office of Public Health (FOPH) has joined the Bluesky social network, while US President Donald Trump works with X owner Elon Musk to censor content on official US websites.
Biotech company BioVersys is first Swiss IPO of 2025
This content was published on
The Basel-based biotech company BioVersys made the first initial public offering (IPO) of the year in Switzerland on Friday.
Much more spent on Swiss motorway vote campaigns than budgeted
This content was published on
Opponents and supporters of motorway expansion spent over CHF10 million ($11 million) on their campaigns, around a third more than announced in November.
Swiss researchers monitor animal populations with AI microphone
This content was published on
Researchers in Lausanne are using an intelligent microphone to make the animal world audible. The microphone automatically records animal sounds over large areas and analyses them using AI.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Health office approves first Swiss project to sell cannabis for recreational use
This content was published on
The city of Basel is the first to be given the green light by the Swiss authorities for a scientific trial with cannabis for recreational use.
Majority of Swiss support the legalisation of cannabis
This content was published on
Nearly two-thirds of people surveyed want the minimum age of consumption to be set at 18, the Federal Office of Public Health (FOPH) said. Two-thirds are in favor of conducting pilot tests on the controlled distribution of cannabis for recreational purposes. The survey was conducted by the Sotomo Institute from the end of January to…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.